The MyD88, for instance, is an essential adaptor protein for Toll-like receptor (TLR) signaling, which can suppress M2 gene expression in tumor-associated macrophage (TAMs) and promote tumoricidal M1 phenotype through the activation of TLR4/MyD88/NF-κB pathway 29. The gene discussed is NFKB1; the disease is neoplasm.